18F-FDG primary tumor uptake to improve N status prediction in cT1 non-metastatic non-small cell lung cancer: development and validation of a positron emission tomography model.

Fiche publication

Date publication

avril 2023

Journal

Frontiers in medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CHENARD Marie-Pierre , Pr FALCOZ Pierre-Emmanuel , Pr IMPERIALE Alessio

Tous les auteurs :
Morland D, Chiappetta M, Falcoz PE, Chenard MP, Annunziata S, Boldrini L, Lococo F, Imperiale A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37181374

Résumé

Occult lymph node involvement is a major issue in the management of non-small cell lung carcinoma (NSCLC), with an estimated prevalence of approximately 2.9-21.6% in 18F-FDG PET/CT series. The aim of the study is to construct a PET model to improve lymph node assessment.